Nefazodone Treatment of Adolescent Depression: An Open-Label Study of Response and Biochemistry

References

• Weinberg W, Emslie G: Adolescents and school problems: depression, suicide, and learning disorders. Adv Adolesc Ment Health 1988; 3:181–205.
   Google Scholar
• Rao U, Weissman MM, Martin JA, Hammond RW: Child-hood depression and risk of suicide: a preliminary report of a longitudinal study. J Am Acad Child Adolesc Psychiatry 1993; 32:21–27.
   PubMed Web of Science ®Google Scholar
• Hazel) P. O'Connell D, Heathcote D, Robertson J, Henry D: Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ 1995; 310:897–901.
   Google Scholar
• Boulos C. Kutcher S, Gardner D, Young E: An open naturalis-tic trial of fluoxetine in adolescents and young adults with treatment resistant major depression. J Child Adolesc Psycho-pharmacol 1992; 2:103–111.
   Google Scholar
• Ghaziuddin N, Naylor MW, King CA: Fluoxetine in tricyclic refractory depression in adolescents. Depression 1995; 2:287–291,
   Google Scholar
• JaM U, Birmaher B, Garcia M, Al-Shabbout M, Ryan N: Fluoxetine in children and adolescents with mood disorders: a chart review of efficacy and adverse effects. J Child Adolesc Psychopharmacol 1992; 2:259–265.
   Google Scholar
• Simeon J, Dinicola V, Ferguson HB, Copping W: Adolescent depression: a placebo-controlled fluoxetine treatment study and followup. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14:791–795.
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J: A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adoles-cents with depression. Arch Gen Psychiatry 1997; 54:1031–1037.
   PubMed Web of Science ®Google Scholar
• Tierney E, Paramjit JT, Leinas IF, Rosenberg LA, Riddle MA: Sertraline for major depression in children and adoles-cents: preliminary clinical experience. J Child Adolesc Psycho-pharmacol 1995; 5:13–27.
   Web of Science ®Google Scholar
• Alderman JA, Wolkow R, Johnston JF, Rosenthal MH, Fer-guson JM, Sallee FR, Blumer J: Sertraline treatment in chil-dren and adolescents: Tolerability, efficacy, and pharmacoki-netics. New Research Abstracts, APA Annual Meeting, New York, NY. May 4–9, 1996, pp. 128, #NR222.
   Google Scholar
• Fontaine R, Ontiveros A, Elie R, Kensler IT, Roberts DL, Kaplita S, Ecker JA, Faludi G: A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatry 1994; 55:234–241.
   PubMed Web of Science ®Google Scholar
• Magnus RD, Findling R, Prekorn SH, Friesen S, Marcus R, Marathe F, D'Amico F. An open-label pharmacokinetic trial of nefazodone in depressed children and adolescents. NCDEU Annual Meeting, Boca Raton, Florida, May 27–30, 1997, Poster #110.
   Google Scholar
• Goodnick PJ, Henry J, Kumar A: Neurochemistry and paro-xetine response in major depression. Biol Psychiatry 1995; 37:417–419.
   PubMed Web of Science ®Google Scholar
• Goodnick PJ, Kumar A, Henry JH, Buki VMV, Goldberg RB: Sertraline in coexisting major depression and diabetes mellitus. Psycopharmacol Bull 1997; 33(4261–264.
   Google Scholar
• Nunez R. Goodnick PJ, Doran WE, Freund B, Kumar A: Citalopram in depression: Response & serotonin. New Re-search, APA Annual Meeting, Washington DC, May 15–20, 1999, p. 100, #NR138.
   Google Scholar
• Celada P, Dolera M, Alvarez E: Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet sero-tonin in the blood of major depressive patients. Relationship to clinical outcome. J Affect Dis 1992; 25:243–250.
   PubMed Web of Science ®Google Scholar
• Narayan M, Anderson G, Cellar J, Mallison RT, Price LH, Nelson JC: Serotonin transport-blocking properties of net azo-done assessed by measurement of platelet serotonin. J Clin Psychopharmacol 1998; 18:67–71.
   PubMed Web of Science ®Google Scholar
• Kumar AM, Kumar M, Krishnaprasad D. A modified HPLC technique for simultaneous measurement of 5-hydroxy-tryptamine and 5-hydroxyindoleacetic acid in cerebro-spinal fluid, platelets, and plasma. Life Sci 1990; 47:1751–1759.
   Google Scholar
• Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS: Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and sexual function and satisfaction. J Clin Psychiatry 1996; 57:Suppl.
   Google Scholar
• Bakish D, Cavazzoni P. Chudzik 3, Ravindran A, Hrdina PD: Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psy-chiatry 1997; 41:184–190.
   PubMed Web of Science ®Google Scholar